https://seaportinsurance.com/news-blog/ 2025-03-31T16:50:54+00:00 https://seaportinsurance.com/a-peptide-may-be-compoundable-but-is-it-insurable-what-clinic-owners-need-to-ask/ 2026-08-03T02:28:35+00:00 https://seaportinsurance.com/when-product-training-creates-liability-risks-for-biologics-companies-and-their-sales-representatives/ 2026-08-03T02:24:28+00:00 https://seaportinsurance.com/when-does-a-medical-clinic-become-a-product-distributor-the-hidden-liability-of-dispensing-peptides-supplements-hormones-and-biologics/ 2026-08-03T02:20:03+00:00 https://seaportinsurance.com/what-insurance-does-a-biologics-distributor-need-a-coverage-guide-for-2026/ 2026-08-03T02:13:55+00:00 https://seaportinsurance.com/research-use-only-peptides-in-clinical-practice-why-the-label-does-not-eliminate-liability/ 2026-08-03T02:06:58+00:00 https://seaportinsurance.com/opening-a-regenerative-medicine-clinic-the-insurance-checklist-to-complete-before-your-first-patient/ 2026-08-03T02:00:54+00:00 https://seaportinsurance.com/is-your-biologics-vendor-actually-insured-how-clinics-should-review-a-certificate-of-insurance/ 2026-08-03T01:54:50+00:00 https://seaportinsurance.com/compounded-glp-1-enforcement-in-2026-insurance-and-advertising-risks-for-weight-loss-clinics/ 2026-08-03T01:48:38+00:00 https://seaportinsurance.com/cold-chain-shipping-and-storage-failures-who-is-liable-when-a-biologic-is-compromised/ 2026-08-03T01:42:07+00:00 https://seaportinsurance.com/before-your-clinic-buys-peptides-exosomes-or-biologics-important-vendor-due-diligence-questions/ 2026-08-03T01:36:48+00:00 https://seaportinsurance.com/after-the-july-2026-fda-peptide-meeting-what-clinics-compounders-and-distributors-should-review-now/ 2026-08-03T01:27:53+00:00 https://seaportinsurance.com/a-patient-adverse-event-has-occurred-a-response-plan-for-clinics-and-biologics-suppliers/ 2026-08-03T01:12:55+00:00 https://seaportinsurance.com/claims-made-vs-occurrence-malpractice-insurance-for-clinic-owners/ 2026-06-18T17:55:20+00:00 https://seaportinsurance.com/are-stem-cells-exosomes-and-whartons-jelly-fda-approved-what-clinics-and-biologics-companies-need-to-know-about-liability/ 2026-06-18T17:50:27+00:00 https://seaportinsurance.com/umbilical-cord-stem-cells-cord-blood-and-whartons-jelly-key-differences-and-insurance-risks-for-clinics-and-biologics-companies/ 2026-06-16T02:43:25+00:00 https://seaportinsurance.com/medical-director-and-contractor-coverage-who-is-covered-by-your-clinic-insurance-policy/ 2026-06-16T02:35:30+00:00 https://seaportinsurance.com/whartons-jelly-vs-stem-cells-insurance-product-liability-and-fda-risk-for-regenerative-medicine-businesses/ 2026-06-15T23:54:34+00:00 https://seaportinsurance.com/regenerative-medicine-insurance-coverage-gaps-clinics-should-review/ 2026-06-15T23:50:08+00:00 https://seaportinsurance.com/stem-cells-vs-exosomes-key-differences-fda-considerations-and-insurance-risks-for-clinics-and-biologics-companies/ 2026-06-15T23:44:30+00:00 https://seaportinsurance.com/clinic-professional-liability-insurance-what-to-review-before-renewal/ 2026-06-15T23:37:38+00:00 https://seaportinsurance.com/stem-cells-exosomes-and-whartons-jelly-insurance-and-liability-risks-for-clinics-and-biologics-companies/ 2026-06-15T23:30:18+00:00 https://seaportinsurance.com/how-to-review-insurance-coverage-for-a-regenerative-medicine-or-biologics-business/ 2026-06-15T23:23:18+00:00 https://seaportinsurance.com/product-liability-insurance-for-regenerative-adjacent-nutraceutical-and-supplement-brands/ 2026-05-23T16:08:34+00:00 https://seaportinsurance.com/why-regenerative-medicine-clinics-should-review-product-liability-before-selling-supplements-peptides-or-protocol-bundles/ 2026-05-23T16:03:41+00:00 https://seaportinsurance.com/white-label-supplements-in-regenerative-medicine-who-owns-the-product-liability-risk/ 2026-05-23T15:57:33+00:00 https://seaportinsurance.com/stem-cell-support-peptides-and-longevity-claims-where-supplement-marketing-can-create-insurance-gaps/ 2026-05-23T15:48:22+00:00 https://seaportinsurance.com/from-supplement-brand-to-regenerative-medicine-channel-liability-risks-when-nutraceuticals-move-into-clinics/ 2026-05-23T15:42:13+00:00 https://seaportinsurance.com/when-supplement-brands-use-regenerative-medicine-language-why-product-liability-may-be-more-complex-than-you-think/ 2026-05-23T15:35:39+00:00 https://seaportinsurance.com/the-regenerative-adjacent-supplement-market-product-liability-risks-for-nutraceutical-brands-entering-regenerative-medicine/ 2026-05-23T15:30:38+00:00 https://seaportinsurance.com/muse-cells-explained-clearing-up-the-confusion-around-stem-cells-and-emerging-regenerative-medicine/ 2026-05-06T04:47:29+00:00 https://seaportinsurance.com/muse-cells-vs-mscs-what-clinics-should-understand-before-marketing-emerging-cell-therapies/ 2026-05-06T04:38:39+00:00 https://seaportinsurance.com/indemnification-is-not-insurance-product-liability-risks-for-private-label-regenerative-medicine-brands/ 2026-05-06T04:33:45+00:00 https://seaportinsurance.com/muse-cell-therapy-and-product-liability-what-manufacturers-distributors-private-labels-and-clinics-need-to-know/ 2026-05-05T16:35:43+00:00 https://seaportinsurance.com/private-label-and-white-label-biologics-product-liability-risks-in-regenerative-medicine/ 2026-05-05T16:27:04+00:00 https://seaportinsurance.com/regenerative-medicine-3pl-and-fulfillment-risk-product-liability-gaps-in-storage-shipping-and-chain-of-custody/ 2026-04-28T18:24:03+00:00 https://seaportinsurance.com/white-label-private-label-and-distribution-risk-product-liability-insurance-in-regenerative-medicine/ 2026-04-25T16:17:44+00:00 https://seaportinsurance.com/product-liability-insurance-for-regenerative-medicine-companies-what-manufacturers-distributors-and-biologics-brands-need-to-know/ 2026-04-25T16:09:37+00:00 https://seaportinsurance.com/fda-scrutiny-product-claims-and-product-liability-insurance-in-regenerative-medicine/ 2026-04-25T16:05:55+00:00 https://seaportinsurance.com/pt-141-peptide-vs-viagra-and-cialis-what-clinics-need-to-know-before-offering-both/ 2026-04-02T13:28:31+00:00 https://seaportinsurance.com/peptide-therapy-insurance-risk-understanding-professional-vs-product-liability-for-regenerative-clinics/ 2026-03-01T04:25:39+00:00 https://seaportinsurance.com/multi-state-risk-in-telehealth-trt-and-hrt-clinics-compliance-licensing-and-liability-explained/ 2026-03-01T04:16:10+00:00 https://seaportinsurance.com/prp-and-the-fda-how-advertising-claims-can-trigger-regulatory-risk-for-regenerative-clinics/ 2026-03-01T04:00:59+00:00 https://seaportinsurance.com/ketamine-therapy-clinics-in-2026-regulatory-risk-controlled-substance-compliance-and-the-emerging-malpractice-landscape/ 2026-03-01T03:56:51+00:00 https://seaportinsurance.com/prp-malpractice-trends-in-2026-the-changing-landscape-of-complication-claims/ 2026-03-01T03:45:23+00:00 https://seaportinsurance.com/ketamine-infusion-clinics-professional-malpractice-facility-risk-and-product-liability-exposure-explained/ 2026-03-01T03:36:11+00:00 https://seaportinsurance.com/subscription-based-medical-models-hidden-malpractice-and-coverage-gaps-for-scaling-clinics/ 2026-03-01T03:31:42+00:00 https://seaportinsurance.com/fda-oversight-of-ozone-therapy-documentation-standards-every-regenerative-clinic-should-understand/ 2026-03-01T03:22:42+00:00 https://seaportinsurance.com/testosterone-replacement-therapy-trt-liability-cardiovascular-risk-and-the-growing-malpractice-exposure-for-clinics/ 2026-03-01T03:17:16+00:00 https://seaportinsurance.com/compounded-peptide-therapy-liability-the-insurance-gaps-most-regenerative-clinics-overlook/ 2026-03-01T03:10:40+00:00 https://seaportinsurance.com/weight-loss-peptide-liability-the-growing-malpractice-risk-for-clinics-prescribing-glp-1-and-compounded-therapies/ 2026-02-19T04:15:43+00:00 https://seaportinsurance.com/telehealth-ketamine-prescribing-in-2026-multi-state-liability-dea-oversight-and-insurance-gaps-explained/ 2026-02-19T04:08:36+00:00 https://seaportinsurance.com/prp-liability-exposure-in-2026-what-regenerative-clinics-overlook-after-1000-procedures-and-why-it-matters/ 2026-02-19T04:05:22+00:00 https://seaportinsurance.com/ozone-generator-liability-understanding-product-vs-professional-risk-in-integrative-clinics/ 2026-02-19T03:57:22+00:00 https://seaportinsurance.com/integrative-medicine-liability-risk-how-wellness-and-regenerative-clinics-can-unintentionally-increase-exposure/ 2026-02-19T03:50:09+00:00 https://seaportinsurance.com/exosome-therapy-malpractice-risk-why-professional-liability-claims-may-surge-in-2026/ 2026-02-19T03:43:18+00:00 https://seaportinsurance.com/351-vs-361-hct-p-rules-how-fda-classification-determines-the-survival-of-regenerative-clinics/ 2026-02-19T03:31:05+00:00 https://seaportinsurance.com/why-biologics-manufacturers-cant-ignore-how-their-products-are-used-offshore/ 2026-01-30T17:04:07+00:00 https://seaportinsurance.com/when-risk-travels-upstream-what-biologics-manufacturers-must-understand-about-clinic-level-exposure/ 2026-01-30T16:43:48+00:00 https://seaportinsurance.com/regenerative-medicine-in-the-u-s-why-clinics-playing-by-the-rules-will-outlast-offshore-competition/ 2026-01-30T16:38:25+00:00 https://seaportinsurance.com/growth-scrutiny-and-survival-what-u-s-regenerative-clinics-must-understand-as-offshore-competition-accelerates/ 2026-01-20T18:01:44+00:00 https://seaportinsurance.com/why-regulatory-discipline-is-becoming-a-competitive-advantage-in-u-s-regenerative-medicine/ 2026-01-20T17:04:53+00:00 https://seaportinsurance.com/chain-of-custody-matters-the-growing-risk-of-uncontrolled-biologic-use-in-regenerative-medicine/ 2026-01-20T17:01:00+00:00 https://seaportinsurance.com/the-asymmetric-risk-facing-u-s-regenerative-clinics-and-why-offshore-providers-dont-play-by-the-same-rules/ 2026-01-20T16:51:45+00:00 https://seaportinsurance.com/as-regenerative-medicine-scales-globally-biologics-manufacturers-face-a-new-class-of-risk/ 2026-01-20T16:40:52+00:00 https://seaportinsurance.com/the-hidden-downstream-risk-facing-u-s-biologics-manufacturers-in-regenerative-medicine/ 2026-01-20T16:30:11+00:00 https://seaportinsurance.com/the-biggest-insurance-mistakes-clinics-make-when-adding-stem-cells-prp-or-exosomes/ 2025-11-22T20:53:03+00:00 https://seaportinsurance.com/how-to-safely-add-regenerative-medicine-services-to-your-existing-practice-in-2026/ 2025-11-22T19:10:02+00:00 https://seaportinsurance.com/building-a-regenerative-treatment-menu-pricing-consent-sops-and-insurance-requirements-for-clinics-in-2026/ 2025-11-22T19:02:44+00:00 https://seaportinsurance.com/professional-vs-product-liability-the-insurance-framework-every-regenerative-clinic-must-have/ 2025-11-22T18:41:13+00:00 https://seaportinsurance.com/the-new-wave-why-weight-loss-wellness-clinics-are-expanding-into-regenerative-medicine/ 2025-11-22T18:32:04+00:00 https://seaportinsurance.com/why-traditional-malpractice-insurance-does-not-cover-regenerative-medicine-what-clinics-must-know-in-2026/ 2025-11-22T18:23:17+00:00 https://seaportinsurance.com/navigating-insurance-for-non-fda-approved-therapies-how-integrative-and-regenerative-clinics-can-qualify-for-coverage/ 2025-11-07T21:54:43+00:00 https://seaportinsurance.com/from-prp-to-peptides-inside-the-risk-framework-insurers-use-for-emerging-regenerative-treatments/ 2025-11-07T21:50:10+00:00 https://seaportinsurance.com/understanding-underwriting-criteria-for-off-label-and-experimental-medical-procedures-what-providers-need-to-know/ 2025-11-07T21:43:16+00:00 https://seaportinsurance.com/fda-warning-letters-and-their-impact-on-the-peptide-market/ 2025-10-21T21:08:40+00:00 https://seaportinsurance.com/compounding-pharmacies-and-peptides-the-hidden-compliance-trap/ 2025-10-21T21:00:59+00:00 https://seaportinsurance.com/peptide-innovation-and-risk-the-next-frontier-in-regenerative-medicine/ 2025-10-21T19:52:53+00:00 https://seaportinsurance.com/growth-factors-in-regenerative-medicine-advancing-musculoskeletal-healing-and-the-role-of-liability-insurance/ 2025-10-10T19:26:21+00:00 https://seaportinsurance.com/from-umbilical-cord-to-clinic-how-whartons-jelly-stem-cells-support-musculoskeletal-repair-and-the-role-of-liability-insurance/ 2025-10-10T19:24:54+00:00 https://seaportinsurance.com/from-sports-injuries-to-surgical-repair-how-regenerative-medicine-supports-tendon-to-bone-healing-and-why-liability-insurance-matters/ 2025-10-10T19:16:35+00:00 https://seaportinsurance.com/from-inflammation-control-to-tissue-repair-the-role-of-cytokines-in-regenerative-medicine-and-why-liability-insurance-matters/ 2025-10-10T19:09:42+00:00 https://seaportinsurance.com/whartons-jelly-in-regenerative-medicine-musculoskeletal-healing-potential-and-why-liability-insurance-matters/ 2025-09-25T18:43:26+00:00 https://seaportinsurance.com/a-complete-guide-to-regenerative-therapies-for-musculoskeletal-pain-from-platelet-rich-plasma-to-stem-cell-injections/ 2025-09-25T18:39:48+00:00 https://seaportinsurance.com/from-stem-cells-to-exosomes-biologics-driving-musculoskeletal-healing-and-why-liability-insurance-matters/ 2025-09-25T18:32:22+00:00 https://seaportinsurance.com/ketamine-clinics-and-regenerative-medicine-patient-benefits-provider-risks-and-liability-insurance-solutions/ 2025-09-25T18:26:31+00:00 https://seaportinsurance.com/cytokines-in-regenerative-medicine-musculoskeletal-repair-clinical-risks-and-the-need-for-liability-insurance/ 2025-09-25T17:12:59+00:00 https://seaportinsurance.com/biologics-for-musculoskeletal-disorders-patient-outcomes-provider-risks-and-liability-insurance-solutions/ 2025-09-25T16:58:42+00:00 https://seaportinsurance.com/tendon-to-bone-healing-in-regenerative-medicine-breakthrough-therapies-and-the-importance-of-liability-insurance/ 2025-09-25T16:58:25+00:00 https://seaportinsurance.com/new-florida-law-makes-improper-stem-cell-administration-a-felony-seaport-insurance-responds-with-safeguards-for-clinics-and-physicians/ 2025-09-06T00:09:43+00:00 https://seaportinsurance.com/telehealth-and-ketamine-emerging-liability-risks-and-insurance-solutions/ 2025-08-22T19:14:20+00:00 https://seaportinsurance.com/ketamine-manufacturers-distributors-how-to-protect-against-product-liability-and-recalls/ 2025-08-22T19:09:04+00:00 https://seaportinsurance.com/compounded-ketamine-and-pharmacy-liability-what-pharmacies-must-know/ 2025-08-22T18:58:05+00:00 https://seaportinsurance.com/spravato-rems-program-insurance-requirements-for-certified-sites/ 2025-08-22T18:52:24+00:00 https://seaportinsurance.com/ketamine-clinic-malpractice-insurance-what-carriers-look-for-in-coverage/ 2025-08-22T18:29:08+00:00 https://seaportinsurance.com/navigating-fda-compliance-for-exosome-therapy-clinics-why-liability-insurance-is-non-negotiable/ 2025-06-26T13:59:48+00:00 https://seaportinsurance.com/regenerative-medicine-liability-insurance-essential-coverage-for-emerging-therapies-2/ 2025-06-26T13:55:18+00:00 https://seaportinsurance.com/ozone-therapy-and-professional-liability-essential-insurance-for-clinics-navigating-regulatory-and-patient-risks-2/ 2025-06-26T13:51:33+00:00 https://seaportinsurance.com/navigating-malpractice-insurance-for-integrative-medicine-protecting-your-practice-in-a-holistic-healthcare-landscape/ 2025-06-26T13:44:08+00:00 https://seaportinsurance.com/fda-483-and-peptide-therapy-professional-liability-insurance-for-clinics-facing-compliance-risks-2/ 2025-06-26T13:39:27+00:00 https://seaportinsurance.com/safeguarding-your-peptide-therapy-practice-top-professional-liability-insurance-options-for-clinics-2/ 2025-06-26T13:31:01+00:00 https://seaportinsurance.com/ozone-therapy-clinics-and-fda-483-why-professional-liability-insurance-is-critical-for-compliance/ 2025-06-07T21:55:09+00:00 https://seaportinsurance.com/safeguarding-your-peptide-therapy-practice-top-professional-liability-insurance-options-for-clinics/ 2025-06-07T21:54:54+00:00 https://seaportinsurance.com/fda-compliance-for-exosome-therapy-clinics-why-liability-insurance-is-non-negotiable/ 2025-06-07T21:37:46+00:00 https://seaportinsurance.com/exosome-therapy-the-next-frontier-in-regenerative-medicine-and-its-hidden-liability-risks/ 2025-05-30T16:11:31+00:00 https://seaportinsurance.com/ozone-therapy-and-professional-liability-essential-insurance-for-clinics-navigating-regulatory-and-patient-risks/ 2025-05-24T14:24:31+00:00 https://seaportinsurance.com/regenerative-medicine-liability-insurance-essential-coverage-for-emerging-therapies/ 2025-05-24T14:17:25+00:00 https://seaportinsurance.com/fda-483-and-peptide-therapy-professional-liability-insurance-for-clinics-facing-compliance-risks/ 2025-05-24T14:16:49+00:00 https://seaportinsurance.com/protecting-your-ozone-therapy-clinic-best-professional-liability-insurance-options-for-managing-risks/ 2025-05-15T15:29:51+00:00 https://seaportinsurance.com/peptide-therapy-and-professional-liability-essential-insurance-for-clinics-facing-regulatory-and-patient-risks/ 2025-05-15T15:29:25+00:00 https://seaportinsurance.com/fda-483-in-regenerative-medicine-product-and-professional-liability-insurance-for-manufacturers-and-clinics/ 2025-05-15T15:28:45+00:00 https://seaportinsurance.com/integrative-medicine-liability-insurance-essential-coverage-for-holistic-practitioners/ 2025-05-08T16:45:08+00:00 https://seaportinsurance.com/navigating-malpractice-insurance-for-regenerative-medicine-protecting-your-practice-in-a-rapidly-evolving-field/ 2025-05-08T15:48:30+00:00 https://seaportinsurance.com/regenerative-medicine-liability-exposed-7-real-world-scenarios-that-could-put-your-practice-at-risk/ 2025-05-08T15:19:53+00:00 https://seaportinsurance.com/liability-insurance-for-regenerative-medicine-what-every-clinic-and-med-spa-needs-to-know-in-2025/ 2025-04-28T14:24:41+00:00 https://seaportinsurance.com/emerging-therapies-rising-risks-why-exosome-prp-and-amniotic-based-treatments-require-specialized-insurance/ 2025-04-28T14:24:23+00:00 https://seaportinsurance.com/top-legal-risks-facing-regenerative-medicine-product-manufacturers-and-how-the-right-insurance-can-protect-you/ 2025-04-28T14:24:08+00:00 https://seaportinsurance.com/stem-cell-therapy-liability-professional-insurance-for-regenerative-medicine-practitioners/ 2025-04-28T14:23:14+00:00 https://seaportinsurance.com/is-your-regenerative-medicine-practice-protected-why-professional-liability-insurance-is-non-negotiable/ 2025-04-28T14:21:42+00:00 https://seaportinsurance.com/do-you-need-product-liability-insurance-for-stem-cell-peptide-or-vitamin-injections-a-complete-guide-for-regenerative-medicine-manufacturers-and-medical-professionals/ 2025-04-28T14:21:08+00:00